Thomas Grima graduated with a B.Sc. (Hons) in Biomedical Science s in 2014 and then completed his Master’s in Science (M.Sc.) at the University college of London (UCL) in Biomaterials and Tissue Engineering in 2016. At UCL, Thomas proved that ultrasound has the potential to revolutionise 3d printing.  After completing his M.Sc., Thomas worked in cutting edge life sciences manufacturing, most notably as the production lead at the ex-Wolfson Gene Therapy Unit, which eventually became part of MeiraGTx. While in Malta, he has spent just short of the last 5 years employed as Medical Scientific Liaison educating local health practitioners on how, when and why to use medical cannabis and is currently looking for new opportunities.